inforMED
MalfunctionGMQ

BD MACRO-VUE¿ RPR CARD TEST

Received May 31, 2023 · Event occurred May 8, 2023

Report 3008352382-2023-00091 · MDR key 17028570

Device

Generic name

Antigens, Nontreponemal, All

Model number

275005

Catalog number

275005

Lot number

2311227

Product problems

  • False Negative Result
  • False Negative Result

Patient

Unknown

  • No Clinical Signs, Symptoms or Conditions
  • No Clinical Signs, Symptoms or Conditions

Narrative

Additional Manufacturer Narrative

H.6. INVESTIGATION SUMMARY: CATALOG: 275005, LOT NUMBER: 2311227. SATISFACTORY RESULTS WHEN RETENTION SAMPLES WERE TESTED FOR PERFORMANCE USING THREE (3) SERA PANEL NUMBERS OF EACH REACTIVITY. TEST WAS PERFORMED USING DISPENTIRS AND MICROPIPETTE. NO DISCREPANCY WAS OBSERVED. CONTROL LOT: (3009503), CUSTOMER BATCH NUMBER: (2311227). ENCLOSED RESULTS USING MICROPIPETTES AND DISPENTIRS. SERUM NO. 15: ALL LOTS SHOWED REACTIVE RESULTS AT 1:1 TO 1:4 AND REACTIVE MINIMAL AT 1:8. SERUM NO. 18: ALL LOTS SHOWED REACTIVE RESULTS AT 1:1 AND REACTIVE MINIMAL AT 1:2. SERUM NO. 19: ALL LOTS SHOWED REACTIVE RESULTS AT 1:1 TO 1:2 AND REACTIVE MINIMAL AT 1:4. SERUM NO¿S. 29, 34 AND 38: ALL LOTS SHOWED REACTIVE MINIMAL RESULTS AT 1:1 SERUM NO'S. 3, 4, 7: ALL LOTS SHOWED NEGATIVE RESULTS. TWO PHOTO RECEIVED, REACTION ON WELL CAN'T BE DEFINED DUE TO THE REFLECTION OF THE LIGHT AND UNKNOWN TIME REACTION TIME WE WERE UNABLE TO REPRODUCED CUSTOMER INQUIRED. ANTIGEN PERFORMANCE WAS AS EXPECTED. BOTH TEST YIELD IN SAME REACTIVITY. DEVICE HISTORY RECORD (DHR) REVIEW WAS SATISFACTORY; NO DEVIATIONS WERE REPORTED. IN-PROCESS AND QC TESTING WERE WITHIN SPECIFICATION.

Description of Event or Problem

REPORT 2 OF 3. IT WAS REPORTED THAT BD MACRO-VUE¿ RPR CARD TEST. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: 3 INCIDENTS OF RESULTS DISCREPANCY OVER THE LAST FEW MONTHS THERE HAS BEEN SOME INCIDENTS WHEN USING THE DISPOSABLE DISPENSTIRS PATIENTS APPEARED NONREACTIVE, BUT THE PATIENTS HAVE HAD A HISTORY OF BEING REACTIVE. WHEN WE USE THE MLA MICROPIPETTE TO DISPENSE 50 UL THERE IS A SIGNIFICANT INCREASE IN REACTIVITY. ERRONEOUS RESULT WAS REPORTED. A NONREACTIVE RPR WAS REPORTED ON A PATIENT; ONE OF OUR CLIENTS TESTED THAT PATIENT USING THE SAME BD MACRO-VUE RPR KIT AND RECEIVED A REACTIVE RESULT. THERE WAS NO IMPACTED TO THE PATIENT AS OUR CLIENT TREATED THE PATIENT.

Description of Event or Problem

REPORT 2 OF 3 IT WAS REPORTED THAT BD MACRO-VUE¿ RPR CARD TEST THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: 3 INCIDENTS OF RESULTS DISCREPANCY OVER THE LAST FEW MONTHS THERE HAS BEEN SOME INCIDENTS WHEN USING THE DISPOSABLE DISPENSTIRS PATIENTS APPEARED NONREACTIVE, BUT THE PATIENTS HAVE HAD A HISTORY OF BEING REACTIVE. WHEN WE USE THE MLA MICROPIPETTE TO DISPENSE 50 UL THERE IS A SIGNIFICANT INCREASE IN REACTIVITY. ERRONEOUS RESULT WAS REPORTED. A NONREACTIVE RPR WAS REPORTED ON A PATIENT; ONE OF OUR CLIENTS TESTED THAT PATIENT USING THE SAME BD MACRO-VUE RPR KIT AND RECEIVED A REACTIVE RESULT. THERE WAS NO IMPACTED TO THE PATIENT AS OUR CLIENT TREATED THE PATIENT.

Additional Manufacturer Narrative

INITIAL REPORTER EMAIL: (B)(6). A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.